company background image
ADVENZYMES logo

Advanced Enzyme Technologies Informe acción NSEI:ADVENZYMES

Último precio

₹366.35

Capitalización de mercado

₹41.0b

7D

-3.5%

1Y

11.3%

Actualizada

24 Nov, 2024

Datos

Finanzas de la empresa +

Advanced Enzyme Technologies Limited

Informe acción NSEI:ADVENZYMES

Capitalización de mercado: ₹41.0b

Resumen de acción ADVENZYMES

Advanced Enzyme Technologies Limited, junto con sus filiales, se dedica a la investigación, desarrollo, fabricación y comercialización de enzimas y probióticos en India, Europa, Estados Unidos, Asia y a escala internacional. Saber más

Análisis fundamental de ADVENZYMES
Puntuación del snowflake
Valoración4/6
Crecimiento futuro4/6
Rendimiento pasado4/6
Salud financiera6/6
Dividendos4/6

Competidores de Advanced Enzyme Technologies Limited

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Advanced Enzyme Technologies
Precios históricos de las acciones
Precio actual de la acción₹366.35
Máximo en las últimas 52 semanas₹571.00
Mínimo de 52 semanas₹324.65
Beta0.40
1Cambio en 1 mes-16.07%
Variación en 3 meses-20.96%
Cambio de 1 año11.28%
3Variación en 3 años8.82%
Variación en 5 años121.29%
Variación desde la OPV33.20%

Noticias y actualizaciones recientes

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03
Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13
With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28
Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18
Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03
I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28
What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05
Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21
What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Rentabilidad de los accionistas

ADVENZYMESIN ChemicalsMercado IN
7D-3.5%-0.8%0.5%
1Y11.3%10.7%27.5%

Rentabilidad vs. Industria: ADVENZYMES igualó a la industria Indian Chemicals, que obtuvo un rendimiento del 10.7% el año pasado.

Rentabilidad vs. Mercado: ADVENZYMES obtuvo unos resultados inferiores a los del mercado Indian, que fueron del 27.5% el año pasado.

Volatilidad de los precios

Is ADVENZYMES's price volatile compared to industry and market?
ADVENZYMES volatility
ADVENZYMES Average Weekly Movement7.6%
Chemicals Industry Average Movement5.6%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Precio estable de las acciones: El precio de las acciones de ADVENZYMES ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de ADVENZYMES(8%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de Indian.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1957323Mukund Kabrawww.advancedenzymes.com

Advanced Enzyme Technologies Limited, junto con sus filiales, se dedica a la investigación, el desarrollo, la fabricación y la comercialización de enzimas y probióticos en India, Europa, Estados Unidos, Asia y a escala internacional. La empresa ofrece enzimas y suplementos nutricionales basados en probióticos para la salud humana y la nutrición animal, el procesado de frutas y verduras, la panificación, la elaboración de cerveza y malta, el procesado de almidón y cereales, la modificación de proteínas, el procesado de levaduras, el procesado de lácteos y quesos, y el procesado de aceites y grasas, así como para aplicaciones especializadas, biocombustibles y biocatálisis. Ofrece enzimas no alimentarias para el procesado de textiles, cuero, pasta y papel, así como detergentes y productos de limpieza.

Resumen de fundamentos de Advanced Enzyme Technologies Limited

¿Cómo se comparan los beneficios e ingresos de Advanced Enzyme Technologies con su capitalización de mercado?
Estadísticas fundamentales de ADVENZYMES
Capitalización bursátil₹40.99b
Beneficios(TTM)₹1.37b
Ingresos (TTM)₹6.19b

29.9x

Ratio precio-beneficio (PE)

6.6x

Ratio precio-ventas (PS)

¿Está ADVENZYMES sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de ADVENZYMES
Ingresos₹6.19b
Coste de los ingresos₹1.51b
Beneficio bruto₹4.69b
Otros gastos₹3.32b
Beneficios₹1.37b

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)12.25
Margen bruto75.69%
Margen de beneficio neto22.13%
Ratio deuda/patrimonio1.8%

¿Cómo se ha desempeñado ADVENZYMES a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.4%

Rentabilidad actual por dividendo

42%

Ratio de pagos